[go: up one dir, main page]

ES472435A1 - Procedimiento para la preparacion de derivados de 4-hidroxi-2-bancimidazolinona - Google Patents

Procedimiento para la preparacion de derivados de 4-hidroxi-2-bancimidazolinona

Info

Publication number
ES472435A1
ES472435A1 ES472435A ES472435A ES472435A1 ES 472435 A1 ES472435 A1 ES 472435A1 ES 472435 A ES472435 A ES 472435A ES 472435 A ES472435 A ES 472435A ES 472435 A1 ES472435 A1 ES 472435A1
Authority
ES
Spain
Prior art keywords
medicaments
hydroxy
preparation
hydrogen
benzimidazolinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES472435A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19782801953 external-priority patent/DE2801953A1/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES472435A1 publication Critical patent/ES472435A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procedimiento para la preparación de derivados de 4-hidroxi-2- bencimidazolinona de la fórmula general **Fórmula** en la que R significa un radical alcohilo inferior, R1 y R2, que son iguales o diferentes, significan en cada caso un radical alcohilo inferior, de cadena recta o ramificado, o R1 y R2 significan en común un radical alcohileno, y R3 significa un átomo de hidrógeno o un radical acilo, pudiendo R1 ó R2 ser también hidrógeno, así como sus sales farmacológicamente compatibles.
ES472435A 1977-08-12 1978-08-08 Procedimiento para la preparacion de derivados de 4-hidroxi-2-bancimidazolinona Expired ES472435A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2736295 1977-08-12
DE19782801953 DE2801953A1 (de) 1978-01-18 1978-01-18 4-hydroxy-2-benzimidazolinon-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ES472435A1 true ES472435A1 (es) 1979-04-16

Family

ID=25772515

Family Applications (1)

Application Number Title Priority Date Filing Date
ES472435A Expired ES472435A1 (es) 1977-08-12 1978-08-08 Procedimiento para la preparacion de derivados de 4-hidroxi-2-bancimidazolinona

Country Status (14)

Country Link
US (1) US4367235A (es)
EP (1) EP0000784B1 (es)
JP (1) JPS5432467A (es)
AT (1) AT364831B (es)
AU (1) AU3888578A (es)
CA (1) CA1108619A (es)
DD (1) DD137584A5 (es)
DE (1) DE2860981D1 (es)
DK (1) DK355378A (es)
ES (1) ES472435A1 (es)
FI (1) FI782452A (es)
IL (1) IL55315A0 (es)
IT (1) IT7826640A0 (es)
PT (1) PT68404A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178413A1 (en) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazoles
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
JPS63156809A (ja) * 1986-12-19 1988-06-29 Shin Etsu Chem Co Ltd 塩化ビニル系重合体の製造方法
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
JPH09502166A (ja) * 1993-07-31 1997-03-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー アドレナリン受容体作動薬活性を有する２−ベンゾヘテロシクリルオキシまたはチオプロパノールアミン誘導体
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
ES2171839T3 (es) * 1996-09-05 2002-09-16 Lilly Co Eli Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
CN103445428A (zh) * 2012-05-28 2013-12-18 苏州科羽电子技术服务有限公司 一种车座手提袋

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (es) * 1976-01-08 1981-07-31 Ciba Geigy Ag

Also Published As

Publication number Publication date
JPS5432467A (en) 1979-03-09
IL55315A0 (en) 1978-10-31
EP0000784A1 (de) 1979-02-21
CA1108619A (en) 1981-09-08
AU3888578A (en) 1980-02-21
DE2860981D1 (en) 1981-11-19
AT364831B (de) 1981-11-25
IT7826640A0 (it) 1978-08-09
US4367235A (en) 1983-01-04
FI782452A (fi) 1979-02-13
PT68404A (de) 1978-09-01
ATA582978A (de) 1981-04-15
EP0000784B1 (de) 1981-08-26
DK355378A (da) 1979-02-13
DD137584A5 (de) 1979-09-12

Similar Documents

Publication Publication Date Title
ES478228A1 (es) Procedimiento para la preparacion de derivados de acidos fe-noxi-alcohilcarboxilicos.
ES476955A1 (es) Un procedimiento para la preparacion de derivados se imida- zoquinazolina.
ES454779A1 (es) Procedimiento para la obtencion de hidroxidiheterociclos eterados.
ES8700851A1 (es) Procedimiento para la obtencion de acido alquil-1- ciclopropil-1, 4-dihidro-4-oxo-3-quinolincarboxilico.
DE3572820D1 (en) 1,4:3,6-dianhydro-hexite derivatives, process for their preparation and their use as medicaments
ES472435A1 (es) Procedimiento para la preparacion de derivados de 4-hidroxi-2-bancimidazolinona
JPS5716822A (en) Use of antipsychotic and adenosine derivative
ES8801207A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas
ES8103071A1 (es) Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol
GB2115815B (en) Benzothiazoline compounds
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
SE7704829L (sv) Indazolyl-(4)-oxi-propanolaminer
FR2458556B1 (es)
NO158677C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater.
FR2413370A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
ES439160A1 (es) Procedimiento para la preparacion de derivados del 4-hidro- xibencimidazol sustituidos con radicales basicos.
CA1257595A (en) 5-HALOGEROVINYL-2'-DESOXYURIDINE DERIVATIVES
ES444957A1 (es) Procedimiento para preparar derivados de acido glicirretini-co.
DE2967665D1 (en) Cardiac rhythm reduction agent
ES434827A1 (es) Procedimiento para la preparacion de derivados aminicos de los azidofenoles.
ES469840A1 (es) Procedimiento para la obtencion de nuevos derivados de tria-zolotiadiacinas.
ES445969A1 (es) Un procedimiento de preparacion de la (fluoro-4-trifluorome-tiltio-3-fenil)-1-piperazina.
SE7905025L (sv) Tereftalsyramonoamidderivat, forfarande for framstellning derav och antiallergiskt medel
GB2000767A (en) Therapeutic propylamine derivatives